-
Publication Venue For
-
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan..
9:19.
2023
-
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013..
8:134.
2022
-
In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence..
8:111.
2022
-
Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ..
8:105.
2022
-
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer..
8:103.
2022
-
Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences..
8:73.
2022
-
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC..
8:12.
2022
-
Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients.
7.
2021
-
Author Correction: Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates..
7:126.
2021
-
Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates..
7:85.
2021
-
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients..
7:77.
2021
-
Anti-tumor effects of an ID antagonist with no observed acquired resistance..
7:58.
2021
-
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study..
7:57.
2021
-
Unmasking the immune microecology of ductal carcinoma in situ with deep learning..
7:19.
2021
-
A medicare-based comparative mortality analysis of active surveillance in older women with DCIS..
6:57.
2020
-
A medicare-based comparative mortality analysis of active surveillance in older women with DCIS..
6:57.
2020
-
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer..
6:3.
2020
-
Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype..
4:30.
2018
-
TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases..
4:13.
2018
-
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas..
2:16007.
2016
-
Unmasking the immune microecology of ductal carcinoma in situ with deep learning
2021
-
Molecular determinants of post-mastectomy breast cancer recurrence.
2018